She states this problem occurred approximately 6 years ago. It began under her axillae, bilaterally. She had it surgically removed with relief of the symptoms in this area. She also complains of this condition underneath her breasts. She requires numerous abdominal pads throughout the day to collect the extensive drainage from her vulva. It has been worsening over the last 6 months.
What do you think is the likely diagnosis of her vulvar condition? Home Study Course & 267 discharge also appear. The prevalence of hidradenitis suppurativa is described as anywhere from 1:100 to 1:600. Women are more commonly affected than men, in a ratio of up to 4:1. d Figure 2 . (Fistula-in-ano) A fistula-in-ano is a hollow tract, connecting a primary opening inside the anal canal to a secondary opening in the perianal skin. It is lined with granulation tissue. The male-to-female ratio is 1. Recurrence rates are high with local excision of focal lesions. Vulvectomy is felt to be the most effective treatment of chronic and extensive disease. However, the best method of closure remains controversial.
Healing by secondary intention is felt by many to be the criterion standard after surgery for hidradenitis suppurativa. More recently, however, skin grafts and flaps have been used to close these extensive surgical excisions. Before surgery, it is imperative that the patient be thoroughly prepared regarding the anticipated extent of surgery, prolonged healing time required, and need for careful postoperative care. The risk of recurrence at the edges of the surgical site must also be discussed.
b
If a cancer is to develop in a patient with hidradenitis suppurativa, squamous cell carcinoma is the most frequent type. Squamous cell carcinoma is usually seen in patients who have suffered from hidradenitis suppurativa for 10 years or more, will often be advanced in stage at diagnosis, and pursue an aggressive clinical course.
